An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Bladder Cancer: Diagnosis and Management.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Care Excellence (NICE); 2015 Feb. (NICE Guideline, No. 2.)
Addendum to Clinical Guideline 81, Advanced Breast Cancer.
London: National Institute for Health and Care Excellence (NICE); 2017 Aug. (Clinical Guideline Addendum, No. 81.2.)
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. 2nd edition.
Geneva: World Health Organization; 2021.
Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2011 Apr. (NICE Clinical Guidelines, No. 122.)
WHO Guidelines for Treatment of Cervical Intraepithelial Neoplasia 2–3 and Adenocarcinoma in situ: Cryotherapy, Large Loop Excision of the Transformation Zone, and Cold Knife Conization.
Geneva: World Health Organization; 2014.
Non-Hodgkin's Lymphoma: Diagnosis and Management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Comprehensive Primary Care for Adults With HIV [Internet].
Dyer M, Kerr C, Fine SM, et al.
Baltimore (MD): Johns Hopkins University; 2022 Dec.
Selpercatinib (Retevmo): CADTH Reimbursement Recommendation: Indication: For the treatment of RET-mutant medullary thyroid cancer in adult and pediatric patients 12 years of age and older with unresectable advanced or metastatic disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.
Ibrutinib (Imbruvica): CADTH Reimbursement Recommendation: Indication: Ibrutinib in combination with venetoclax for the treatment of adult patients with previously untreated chronic lymphocytic leukemia, including those with 17p deletion [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Tisagenlecleucel (Kymriah): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with relapsed or refractory grade 1, 2, or 3a follicular lymphoma after 2 or more lines of systemic therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Sep.
Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto): CADTH Reimbursement Recommendation: Indication: Treatment of adults with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer who have received at least one androgen receptor pathway inhibitor and taxane-based chemotherapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto): CADTH Reimbursement Review: Therapeutic area: Metastatic castration-resistant prostate cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda [Internet].
Geneva: World Health Organization; 2022.
Thyroid cancer: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Dec 19. (NICE Guideline, No. 230.)
Addendum to Haematological Cancers: improving outcomes (update).
London: National Institute for Health and Care Excellence (NICE); 2016 May.
Crisantaspase Recombinant (Rylaze): CADTH Reimbursement Recommendation: Indication: As a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 year or older who have developed hypersensitivity to E. coli-derived asparaginase [Internet].
Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 148.)
Evinacumab (Evkeeza): CADTH Reimbursement Recommendation: Indication: As an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
Pelvic floor dysfunction: prevention and non-surgical management.
London: National Institute for Health and Care Excellence (NICE); 2021 Dec 9. (NICE Guideline, No. 210.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on